{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "licensed-patents", "type": "definition", "offset": [13, 29]}, {"key": "licensed-know", "type": "definition", "offset": [41, 54]}], "samples": [{"hash": "iTP5hX6zQxg", "uri": "/contracts/iTP5hX6zQxg#in-licensed-ip", "label": "Platform Technology Transfer and License Agreement (Codexis, Inc.)", "score": 33.1587953457, "published": true}, {"hash": "ftIKnRsLLnF", "uri": "/contracts/ftIKnRsLLnF#in-licensed-ip", "label": "Platform Technology Transfer, Collaboration and License Agreement (Codexis, Inc.)", "score": 31.59137577, "published": true}, {"hash": "bvdFzoQaEc4", "uri": "/contracts/bvdFzoQaEc4#in-licensed-ip", "label": "Platform Technology Transfer and License Agreement (Codexis, Inc.)", "score": 30.5934291581, "published": true}], "size": 10, "snippet": "means the In-Licensed Patents and any In-Licensed Know-How.", "hash": "1af5688efc0dec81f83b8034e35450b8", "id": 1}, {"snippet_links": [{"key": "all-intellectual-property", "type": "clause", "offset": [6, 31]}, {"key": "by-a-third-party", "type": "clause", "offset": [41, 57]}, {"key": "to-the-company", "type": "clause", "offset": [58, 72]}], "samples": [{"hash": "ahkb1TY5Pwf", "uri": "/contracts/ahkb1TY5Pwf#in-licensed-ip", "label": "Merger Agreement (Broadvision Inc)", "score": 21.0, "published": true}, {"hash": "6JJhFEfPqpl", "uri": "/contracts/6JJhFEfPqpl#in-licensed-ip", "label": "Merger Agreement (Bravo Holdco)", "score": 21.0, "published": true}], "size": 8, "snippet": "means all Intellectual Property licensed by a third party to the Company or any of its Subsidiaries.", "hash": "ab6e4f8a56f9dfd2fc48efbf8c951c85", "id": 2}, {"snippet_links": [], "samples": [{"hash": "8XK2ARtF4hV", "uri": "/contracts/8XK2ARtF4hV#in-licensed-ip", "label": "Transition Services Agreement (Organon & Co.)", "score": 32.4195756331, "published": true}, {"hash": "59RTxSWCtFy", "uri": "/contracts/59RTxSWCtFy#in-licensed-ip", "label": "Transition Services Agreement (Organon & Co.)", "score": 32.4195756331, "published": true}, {"hash": "1AGtlYsNi7Y", "uri": "/contracts/1AGtlYsNi7Y#in-licensed-ip", "label": "Transition Services Agreement (Organon & Co.)", "score": 32.2826830938, "published": true}], "size": 5, "snippet": "has the meaning set forth in Section 2.9.3.", "hash": "3498eb16a36f6aa66a90a4f273aff30f", "id": 3}, {"snippet_links": [{"key": "the-patents", "type": "clause", "offset": [6, 17]}], "samples": [{"hash": "b5066XcbyU0", "uri": "/contracts/b5066XcbyU0#in-licensed-ip", "label": "License and Option Agreement (Celldex Therapeutics, Inc.)", "score": 29.1779603012, "published": true}, {"hash": "6r5LAH4uRbs", "uri": "/contracts/6r5LAH4uRbs#in-licensed-ip", "label": "License and Option Agreement (Kolltan Pharmaceuticals Inc)", "score": 25.6954140999, "published": true}, {"hash": "bFdx1Vq0Zn", "uri": "/contracts/bFdx1Vq0Zn#in-licensed-ip", "label": "License and Option Agreement (Kolltan Pharmaceuticals Inc)", "score": 25.5995893224, "published": true}], "size": 3, "snippet": "means the Patents and Know-How set forth on Exhibit 1.42.", "hash": "b9db3ba0d3b36c6a1cad40b084d72fd1", "id": 4}, {"snippet_links": [{"key": "all-intellectual-property", "type": "clause", "offset": [6, 31]}, {"key": "by-a-third-party", "type": "clause", "offset": [38, 54]}, {"key": "to-seller", "type": "definition", "offset": [84, 93]}, {"key": "controlled-affiliates", "type": "definition", "offset": [117, 138]}, {"key": "pursuant-to", "type": "definition", "offset": [139, 150]}, {"key": "assigned-contract", "type": "clause", "offset": [154, 171]}, {"key": "licensed-ip", "type": "definition", "offset": [180, 191]}, {"key": "licensed-patents", "type": "definition", "offset": [208, 224]}], "samples": [{"hash": "hIkJjAXySb5", "uri": "/contracts/hIkJjAXySb5#in-licensed-ip", "label": "Asset Purchase Agreement (Kala Pharmaceuticals, Inc.)", "score": 33.3887748118, "published": true}, {"hash": "c2MJN9CKTGb", "uri": "https://investors.kalarx.com/static-files/55eda53d-a922-433b-bd24-a87b6ba6db7d", "label": "investors.kalarx.com", "score": 11.1943874059, "published": false}], "size": 2, "snippet": "means all Intellectual Property owned by a Third Party for which rights are granted to Seller or its subsidiaries or controlled Affiliates pursuant to an Assigned Contract. The In-Licensed IP includes all In-Licensed Patents.", "hash": "1f75e60f32604056752f99d94d0922cf", "id": 5}, {"snippet_links": [{"key": "to-the-corporation", "type": "clause", "offset": [30, 48]}, {"key": "for-greater-certainty", "type": "clause", "offset": [54, 75]}, {"key": "licenses-to-software", "type": "clause", "offset": [93, 113]}, {"key": "oss-licenses", "type": "clause", "offset": [229, 241]}, {"key": "other-licenses", "type": "definition", "offset": [257, 271]}], "samples": [{"hash": "hS8bL2ORdXg", "uri": "/contracts/hS8bL2ORdXg#in-licensed-ip", "label": "Share Exchange Agreement", "score": 25.4941820671, "published": true}], "size": 2, "snippet": "means all IP that is licensed to the Corporation, and for greater certainty includes (i) any licenses to software-as-a-service, platform-as-a-service, or infrastructure-as-a-service, or any similar cloud-based services, (ii) any OSS licenses, and (iii) any other licenses;", "hash": "8f0571f3ef7ab4cfb1c40a9606a356ae", "id": 6}, {"snippet_links": [{"key": "section-44", "type": "clause", "offset": [29, 40]}], "samples": [{"hash": "jQFnOSUxs7o", "uri": "/contracts/jQFnOSUxs7o#in-licensed-ip", "label": "Development and Supply Agreement (Luna Innovations Inc)", "score": 21.0, "published": true}], "size": 2, "snippet": "has the meaning set forth in Section 4.4.", "hash": "ea42e9fd2e1b5527f4cb8a656ea64888", "id": 7}, {"snippet_links": [{"key": "the-intellectual-property", "type": "definition", "offset": [6, 31]}, {"key": "license-contract", "type": "clause", "offset": [83, 99]}], "samples": [{"hash": "1evCSQlSNET", "uri": "/contracts/1evCSQlSNET#in-licensed-ip", "label": "Stock Purchase Agreement (QLT Inc/Bc)", "score": 21.0, "published": true}], "size": 1, "snippet": "means the Intellectual Property that is licensed to QLT USA under or through an In-License Contract.", "hash": "775cb20605fe6f69d1db32aa6d9bc35c", "id": 8}, {"snippet_links": [], "samples": [{"hash": "eGVBdhfEOSH", "uri": "/contracts/eGVBdhfEOSH#in-licensed-ip", "label": "Share Exchange Agreement (Health Advance, Inc.)", "score": 27.7980835044, "published": true}], "size": 1, "snippet": "means all IP that is licensed to HANTIAN;", "hash": "aa7fd32c086fa98a2584474400282477", "id": 9}, {"snippet_links": [{"key": "business-ip", "type": "clause", "offset": [13, 24]}, {"key": "by-the-company", "type": "clause", "offset": [43, 57]}], "samples": [{"hash": "6E0zBdTkhya", "uri": "/contracts/6E0zBdTkhya#in-licensed-ip", "label": "Asset Purchase Agreement (Teknowledge Corp)", "score": 21.0, "published": true}], "size": 1, "snippet": "means all FS Business IP that is not owned by the Company.", "hash": "1e5138be57de8965822927da6dfade9a", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXaW4tbGljZW5zZWQtaXAjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "In-Licensed IP", "size": 37, "snippet": "means the In-Licensed Patents and any In-Licensed Know-How.", "id": "in-licensed-ip", "examples": ["Without limiting the foregoing, the Company and its Subsidiaries have taken commercially reasonable steps to protect, maintain and enforce all Company IP and Company <strong>In-Licensed IP</strong>, including the secrecy, confidentiality and value of trade secrets and other confidential information therein, and to the Company\u2019s Knowledge there have been no authorized disclosures of any Company IP or Company <strong>In-Licensed IP</strong>.", "Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will conflict with, alter or impair any of the Company\u2019s or its Subsidiaries\u2019 rights in or to any Company IP or Company <strong>In-Licensed IP</strong> or cause any payments of any kind to be due or payable to any Person.", "As of the date of this Agreement, no Legal Proceeding is pending (or, to Parent\u2019s Knowledge, is threatened in writing) (A) against Parent alleging that the operation of the business of Parent infringes or constitutes the misappropriation or other violation of any Intellectual Property Rights of another Person or (B) by Parent alleging that another Person has infringed, misappropriated or otherwise violated any of Parent IP or any Parent <strong>In-Licensed IP</strong>.", "Intrexon hereby covenants that during the Term it shall not directly license Complementary <strong>In-Licensed IP</strong> in the Field except in cooperation with AquaBounty and for the benefit of an AquaBounty Product or the Aquaculture Program.", "The Company Owned IP and the Company <strong>In-Licensed IP</strong> constitutes all of the Intellectual Property Rights necessary for the conduct of the business of the Company and its Subsidiaries as it is currently conducted and as it is currently contemplated to be conducted by the Company and its Subsidiaries.", "Section 3.12(b) of the Parent Disclosure Schedule identifies (i) the name of the applicant/registrant, (ii) the jurisdiction of application/registration, (iii) the application or registration number and (iv) any other co-owners, for each item of Parent <strong>In-Licensed IP</strong> that constitutes Registered IP (the \u201cParent In-Licensed Registered IP\u201d).", "For clarity, and notwithstanding anything to the contrary herein, no license to Bluebird <strong>In-Licensed IP</strong> under any License Agreement described in this Section 1.5(d) shall be deemed to be fully-paid up, it being understood and agreed that in no event shall Celgene be relieved of any obligation to reimburse CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \u201c[***]\u201d.", "No claim is pending or, to OTI\u2019s Knowledge, threatened to the effect that any Assigned Intellectual Property or any <strong>In-Licensed IP</strong> is, or upon consummation of the Transactions will be, invalid or unenforceable.", "As of the date of this Agreement, no Legal Proceeding is pending (or is threatened in writing) (A) against Iris or any of its Subsidiaries alleging that the operation of the businesses of Iris or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Rights of another Person or (B) by Iris or any of its Subsidiaries alleging that another Person has infringed, misappropriated or otherwise violated any of the Iris IP or any Iris <strong>In-Licensed IP</strong>.", "OTI is not aware of any actual, or, to OTI\u2019s Knowledge, threatened or potential, infringement, misappropriation, dilution, conflict or violation of the Assigned Intellectual Property or <strong>In-Licensed IP</strong> or unauthorized manufacture, sale, marketing or use of Products by any Person."], "related": [["licensed-ip", "Licensed IP", "Licensed IP"], ["licensed-ip-rights", "Licensed IP Rights", "Licensed IP Rights"], ["company-licensed-ip", "Company Licensed IP", "Company Licensed IP"], ["licensed-technology", "Licensed Technology", "Licensed Technology"], ["licensed-patents", "Licensed Patents", "Licensed Patents"]], "related_snippets": [], "updated": "2025-07-06T21:56:50+00:00"}, "json": true, "cursor": ""}}